— Palatin Technologies, Inc. (NYSE: PTN) reported a loss of $0.02 per share in the second quarter of 2020, vs $0.01 per share loss expected.
— Q2 revenue stood at $20,610, vs $2.54 million expected. The company had no revenues in the corresponding quarter of last year.
— Operating expenses rose to $5.7 million from to $5.1 million a year ago mainly due to the final payment in connection with the termination of agreement on Vyleesi with Greenhill & Co.
— Palatin is advancing discussions on Vyleesi collaborations for territories outside the currently licensed ones, and anticipates execution in calendar year 2020.
— PTN stock fell 14% on the announcement.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
